Jan 012012

Cytisine is a partial nicotine agonist extracted from acacia seeds. In a single-center trial, West et al randomized 740 smokers to receive either cytisine or placebo for 25 days; they were then followed for 12 months with surveys and periodic biochemical verification.

At 12 months, those receiving cytisine had an 8.4% rate of biochemically verified smoking abstinence, compared with 2.4% in the placebo group. The cytisine users did report more gastrointestinal side effects (5.7% more reporting stomach pain, dyspepsia, nausea, or dry mouth).

Since cytisine only costs $15 for a treatment course, it could become a great option for low-income people who want to quit (who make up a disporportionate amount of smokers, and are less likely to be insured or able to afford pharmaceutical smoking cessation aids).

West R et al. Placebo-Controlled Trial of Cytisine for Smoking Cessation. N Eng J Med 2011; 365:1193-1200.

Get our weekly email update, and explore our library of practice updatesreview articles. and board review questions.

PulmCCM is an independent publication not affiliated with or endorsed by any other organization, society or journal referenced on the website. (Terms of Use | Privacy Policy)

Authors: contribute your work in a guest post.


Cytisine, a cheap seed extract, helped smokers quit (RCT, NEJM)